Infectious SIRS (n = 47) | Non-infectious SIRS (n = 95) | p value | |
---|---|---|---|
Age (year) | 67.8 ± 15.7 | 67.2 ± 13.3 | 0.81 |
Gender, n (%) | 0.77 | ||
Male | 32 (68.1) | 67 (70.5) | |
Female | 15 (31.9) | 28 (29.5) | |
Type of surgery, n (%) | |||
Valve surgery | 16 (34.0) | 36 (37.9) | 0.65 |
CABG | 9 (19.1) | 11 (11.6) | 0.22 |
Vessel replacement | 13 (27.7) | 21 (22.7) | 0.47 |
VAD | 3 (6.4) | 1 (1.1) | 0.11 |
Interventional therapy | 1 (2.1) | 14 (14.7) | 0.02 |
Complex surgery | 5 (10.6) | 12 (12.6) | 0.73 |
BMI, kg/m2 | 21.8 (20.0,26.7) | 22.7 (20.4,24.7) | 0.64 |
Concomitant disease, n (%) | |||
Diabetes mellitus | 18 (38.3) | 25 (26.3) | 0.14 |
Hypertension | 20 (42.6) | 35 (36.8) | 0.51 |
CKD | 19 (40.4) | 21 (22.1) | 0.02 |
CPB duration, min | 197.2 ± 142.5 | 173.6 ± 123.5 | 0.31 |
Aortic cross clamping, min | 99.0 ± 100.1 | 98.3 ± 84.7 | 0.96 |
Operation time, min | 508.9 ± 192.4 | 466.3 ± 174.9 | 0.19 |
Blood loss, mL | 3,512 ± 3,150 | 3,189 ± 2,706 | 0.53 |
APACHE II | 19.0 (15.0,25.0) | 11.0 (9.0,14.0) | 0.001 |
SOFA | 7.0 ± 2.6 | 5.1 ± 2.1 | 0.001 |
PCT, ng/mL | 2.80 (1.24,10.20) | 0.10 (0.06,0.21) | 0.001 |
WBC, ×103/μL | 15.5 (11.0,22.6) | 9.3 (7.2,12.6) | 0.001 |
CRP, mg/dL | 15.8 (12.0,19.9) | 5.8 (2.5,8.9) | 0.001 |
ICU stay, day | 23.0 (12.0,52.0) | 5.0 (3.0,6.0) | 0.001 |
Hospital stay, day | 82.0 (37.0,149.0) | 31.0 (23.0,45.0) | 0.001 |
MV duration, h | 264.0 (40.0,999.0) | 17.0 (10.0,39.0) | 0.001 |
CRRT, n (%) | 26 (55.3) | 5 (5.3) | 0.001 |
PMX-DHP, n (%) | 18 (38.3) | 0 | 0.001 |
ECMO, n (%) | 13 (27.7) | 0 | 0.001 |
DIC, n (%) | 23 (48.9) | 0 | 0.001 |
30-Day mortality, n (%) | 3 (6.38) | 0 | 0.035 |
Hospital mortality, n (%) | 22 (46.8) | 0 | 0.001 |